The Motley Fool

I’d buy these 2 micro-caps before they soar in 2020

Spotting the next opportunity before it breaks out has become less of a hobby and more of a total obsession as I’ve become a more experienced investor. There’s always money to be made in growth sectors – I just wish I had more capital on hand to take advantage of the good companies I research!

Caveat emptor, of course. With fewer daily trades in AIM-listed companies than on the FTSE 100 or FTSE 250, it can be more difficult to sell up if you want out in a hurry.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

But having picked apart their finances I think these smaller UK-listed companies will be among the best performers of 2020.

Shearwater Group

£53m market cap Shearwater Group (LSE:SWG) is an AIM-listed cybersecurity, infosec, and IT risk management business with 400 customers across FTSE 350 firms, government departments, and US Fortune 500 companies.

One of the few British independent businesses in the cybersecurity field, Shearwater has been plugging away nicely in recent years, buying up profitable companies to add to their group and cross-selling products between them to generate better revenue, which I like.

The board, now led by CEO Phil Higgins, has focused on a “buy, focus, grow” strategy, adding penetration and threat testing firm Pentest to its stable in April 2019 for £7.4m.

Behind the scenes there is a lot of product development going on, such as a scanning-as-a-service product that uses machine learning to audit sensitive data on external drives, in cloud applications like Office 365, and in cloud storage, such as Google Drive.

The second half of 2019 represented the maiden profit period for SWG, with revenue swinging up 11% to £16.3m, earnings of £1m and adjusted earnings per share of 2.23p.

News has gone a little quiet in recent weeks, so I’d expect the next major update to send the share price soaring.

YourGene Health

Manchester genetic testing firm YourGene Health (LSE:YGEN) develops non-invasive products for male fertility, and pre-natal screening for cystic fibrosis and other genetic disorders.

What caught my eye about the £88.2m market cap business is their planned expansion to extend genetic testing into cancer detection and prevention. Acquiring Elucigene in April 2019 means the company has been able to expand into the US market and launch its first oncology product.

Like Shearwater, YGEN has just posted its first positive earnings. Revenue is growing strongly, up from £0.1m to £8.8m over the last five years, and directors in the company continue to buy more stock to raise their personal stakes, which bodes well.

CEO Lyn Rees highlighted the firm’s strong prospects in recent half year results to 30 September 2019. Revenue was up 97% with excellent organic growth of 56%, gross profits 141% higher, and net cash “significantly improved” to £3.6m compared to net debt of £12.8m over the previous half.

I usually seek positive language in regulatory updates, backed by strong financial fundamentals, and YGEN has this in spades. “I remain convinced we have a very significant opportunity ahead of us,” Rees noted, adding, “we are confident in our outlook for the year ahead and very excited about the prospects for further growth over the following years“.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…

And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...

It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…

But you need to get in before the crowd catches onto this ‘sleeping giant’.

Click here to learn more.

Tom Rodgers has no current position in the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.